Market Overview

Abiomed Wins Federal Contract to Provide Impalla Platform to Vets

Related ABMD
Clinical Trial Results For Impella RP Right Ventricular Heart Failure Trial "Recover Right" Released At TCT 2014
Wall Street Comfortable With Covidien Buy; Some See Move By Johnson & Johnson

Abiomed, Inc. (Nasdaq: ABMD), a leading provider of breakthrough heart support technologies, today reported that it received approval from the U.S. Department of Veterans Affairs to be included on its authorized Veteran's Administration (VA) Federal Supply Schedule in which Abiomed can provide the Impella® platform to VA medical facilities, Department of Defense (DOD) hospitals and other federal agencies.

This contract allows the Company to make the Impella platform available through an automated online database for the approximately 169 VA facilities and the approximately 42 DOD hospitals in the United States. The five year contract will run until August 2018.

Posted-In: News


Related Articles (ABMD)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters